Entertainment
Tevogen CEO Expresses Gratitude For Unprecedented Public Support Of Company’S Business Model Of Commercial Success Through Patient Accessibility And Reaffirms His Commitment To Share Additional Details In The Coming Days
(MENAFN - GlobeNewsWire - Nasdaq) WARREN, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (–Tevogen– or–Tevogen Bio Holdings Inc.–) (Nasdaq: TVGN ) is a clinical-stage specialty immunotherapy ...
By: menafn
- Oct 19 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS